Is conduction system pacing a panacea for pacemaker therapy?

Stephe Kamalathasan,Maria Paton,John Gierula,Sam Straw,Klaus K. Witte
DOI: https://doi.org/10.1080/17434440.2024.2370827
IF: 3.439
2024-06-25
Expert Review of Medical Devices
Abstract:Introduction While supported by robust evidence and decades of clinical experience, right ventricular apical pacing for bradycardia is associated with a risk of progressive left ventricular dysfunction. Cardiac resynchronization therapy for heart failure with reduced ejection fraction can result in limited electrical resynchronization due to anatomical constraints and epicardial stimulation. In both settings, directly stimulating the conduction system below the atrio-ventricular node (either the bundle of His or the left bundle branch area) has potential to overcome these limitations. Conduction system pacing has met with considerable enthusiasm in view of the more physiological electrical conduction pattern, is rapidly becoming the preferred option of pacing for bradycardia, and is gaining momentum as an alternative to conventional biventricular pacing.
engineering, biomedical
What problem does this paper attempt to address?